News
15d
Live Science on MSNExperimental HIV vaccines show promise in early safety test
Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in both.
HHS' decision "could stagnate research that has the potential to save millions of lives," writes Simon Williams.
10d
ZME Science on MSNThis mRNA HIV Vaccine Produces the Virus-Fighting Antibodies That Have Eluded Researchers for 40 Years
In a small trial across ten U.S. research sites, a novel HIV vaccine candidate has shown a result that has eluded scientists ...
HIV vaccines have been in development for decades, but a long-lasting one has yet to be successful. The mRNA technology offers new opportunities because mRNA produces a more potent antibody ...
HIV vaccine efforts have been slowed by the difficulty of getting neutralizing antibodies to target the correct locations of ...
16d
New Scientist on MSNHuman trials point the way towards an mRNA vaccine against HIV
We may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause ...
The NIH announced three new trials for an HIV vaccine based on mRNA technology. ABC 10News Reporter Jared Aarons takes an In-Depth look at the role San Diego's Scripps Research played in ...
A Phase I trial showed an HIV vaccine was 97 percent effective. Now Moderna's mRNA tech could help it get to market faster.
Functionally, Moderna's HIV vaccine works just like the company's widely-used, extremely effective mRNA COVID-19 vaccine, which teaches the body how to build up an immune response by producing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results